Correction: Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and <i>BRAF</i> <i>V600E</i> mutation
Susana Garcı́a-Silva(Spanish National Cancer Research Centre), Héctor Peinado(Centro Nacional de Biotecnología), Sara Sánchez‐Redondo(Spanish National Cancer Research Centre), Yolanda Ruano(Hospital Virgen de la Salud), Laura Nogués(Spanish National Cancer Research Centre), Ana Amor López(Spanish National Cancer Research Centre), C.A. Rodríguez(Spanish National Cancer Research Centre), Carmen García‐Martín(Spanish National Cancer Research Centre), Pilar Ximénez‐Embún(Spanish National Cancer Research Centre), Laura Santambrogio(Cornell University), Javier Muñoz(Ikerbasque), Pablo L. Ortiz‐Romero(Hospital Universitario 12 De Octubre), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Anna Szumera‐Ciećkiewicz(National Institute of Oncology), Alberto Benito‐Martín(Cornell University), Mikkel Noerholm, Piotr Rutkowski(The Maria Sklodowska-Curie National Research Institute of Oncology), Alberto Hernández‐Barranco(Spanish National Cancer Research Centre), Lisa Meyer, Jasminka Boskovic(Spanish National Cancer Research Centre), Marina S. Mazariegos(Universidad Complutense de Madrid), José Luis Rodríguez‐Peralto(Research Institute Hospital 12 de Octubre), Kay Brinkmann, Cristina Montero(Spanish National Cancer Research Centre), Mary Sue Brady(Memorial Sloan Kettering Cancer Center), Johan Skog(Exosome Diagnostics (United States)), Iwona Kalinowska(The Maria Sklodowska-Curie National Research Institute of Oncology), Rocío Letón
Cited by 20
Related Papers
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
|New England Journal of Medicine|2014|5.3k
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
|Nature Medicine|2012|3.7k
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
|The Lancet|2012|3k
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
|Nature Cell Biology|2015|2.7k
Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
|New England Journal of Medicine|2014|2.7k